These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 10775986)

  • 1. [BVD approach: vaccination and eradication].
    Verberne LR
    Tijdschr Diergeneeskd; 2000 Apr; 125(7):218-21. PubMed ID: 10775986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of symptoms associated with bovine herpesvirus 1 vaccination].
    van Wuijckhuise L; Frankena K; van Oijen MA; Meijer L
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):173-80. PubMed ID: 11285635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine virus diarrhea virus type 2].
    Barkema HW; Bartels CJ; van Wuijckhuise L; Hesselink JW; Holzhauer M; Weber MF; Franken P; Kock PA; Bruschke CJ; Zimmer GM
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):158-65. PubMed ID: 11285633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BVD (bovine virus diarrhea) and IBR (infectious bovine rhinotracheitis): serologic studies on 35 farms].
    Franken P; Sol J; Wentink GH
    Tijdschr Diergeneeskd; 1986 Dec; 111(23):1205-7. PubMed ID: 3027917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic detection and practical consequences of antigenic diversity among bovine viral diarrhea viruses in a vaccinated herd.
    Bolin SR; Littledike ET; Ridpath JF
    Am J Vet Res; 1991 Jul; 52(7):1033-7. PubMed ID: 1654030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine.
    Alvarez M; Bielsa JM; Santos L; Makoschey B
    Vaccine; 2007 Sep; 25(36):6613-7. PubMed ID: 17669560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus.
    Bolin SR; McClurkin AW; Cutlip RC; Coria MF
    Am J Vet Res; 1985 Dec; 46(12):2467-70. PubMed ID: 3002214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves.
    Brar JS; Johnson DW; Muscoplat CC; Shope RE; Meiske JC
    Am J Vet Res; 1978 Feb; 39(2):241-4. PubMed ID: 204233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay assessment of bovine viral diarrhea virus antigen in inactivated vaccines using polyclonal or monoclonal antibodies.
    Ludemann LR; Katz JB
    Biologicals; 1994 Mar; 22(1):21-7. PubMed ID: 8068310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a combined parapox/BVD vaccine.
    Büttner M
    Dev Biol Stand; 1986; 65():221-6. PubMed ID: 3030862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine viral diarrhoea virus serology: antibody response after vaccination.
    Allock J
    Vet Rec; 2001 Feb; 148(7):220. PubMed ID: 11266009
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conclusion of BVD approach].
    Verberne LR
    Tijdschr Diergeneeskd; 2000 May; 125(9):284. PubMed ID: 10950731
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
    Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M
    Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of performance of dairy herds that were or were not vaccinated with a bovine herpes virus 1 marker vaccine in 1998].
    Bartels CJ; Barkema HW; Beiboer ML; Bouma A; Stegeman JA
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):191-7. PubMed ID: 11285639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of IBR-BVD-PI3 infections.
    Mod Vet Pract; 1975 Jul; 56(7):507-9. PubMed ID: 167273
    [No Abstract]   [Full Text] [Related]  

  • 17. Viral and viral protein specificity of antibodies induced in cows persistently infected with noncytopathic bovine viral diarrhea virus after vaccination with cytopathic bovine viral diarrhea virus.
    Bolin SR
    Am J Vet Res; 1988 Jul; 49(7):1040-4. PubMed ID: 2844105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [BVD control: about persistent shedders and "quiet" carriers].
    Verberne LR
    Tijdschr Diergeneeskd; 2000 Nov; 125(21):659-60. PubMed ID: 11109279
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody responses to inactivated vaccines and natural infection in cattle using bovine viral diarrhoea virus ELISA kits: assessment of potential to differentiate infected and vaccinated animals.
    Raue R; Harmeyer SS; Nanjiani IA
    Vet J; 2011 Mar; 187(3):330-4. PubMed ID: 20074985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of serum antibodies to bovine herpesvirus-1 and bovine viral diarrhea virus in beef cattle in Uruguay.
    Guarino H; Núñez A; Repiso MV; Gil A; Dargatz DA
    Prev Vet Med; 2008 Jun; 85(1-2):34-40. PubMed ID: 18280598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.